After-Final Practice: Navigating PTO Options to Compact Patent Prosecution
Utilizing After-Final Consideration Pilot 2.0, Pre-Appeal Conference, and More
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE course will guide patent counsel on the various USPTO options for responding after the final rejection of a patent application. The panel will review the basics of each option and focus on strategic considerations and using different options. The panel will also update participants on the ongoing pilot program, review statistics, and discuss their experiences.
Outline
- The value proposition of various after-final options
- Options if you do not wish to amend: request for reconsideration, pre-appeal, appeal
- Options that allow amendment: amendment after final, AFCP, RCE
- The pilot programs and how effective they are
- Fast-Track Appeals Pilot Program
- After Final Consideration Pilot 2.0 (AFCP 2.0)
- Statistics
- Best practices
Benefits
The panel will review these and other key issues:
- What options are available to patent counsel upon receiving a final rejection of a patent application?
- What should patent counsel consider when determining if--and which--PTO option to use in response to a final rejection?
- How can patent counsel and applicants leverage the PTO options for compact patent prosecution?
Faculty
Dr. Elizabeth A. Doherty, PhD
Partner
McNeill Baur
Dr. Doherty has spent the past 20 years assisting clients in the life sciences with a wide range of U.S. patent law... | Read More
Dr. Doherty has spent the past 20 years assisting clients in the life sciences with a wide range of U.S. patent law issues. Her current work focuses on helping clients develop patent strategies for their research projects, conducting due diligence and freedom to operate analyses, and preparing legal opinions, as well as drafting new patent applications and prosecuting U.S. patent application portfolios. Dr. Doherty has also prepared IPR petitions and assisted a patent owner successfully defend all of its patent claims in an inter partes reexamination before the US Patent and Trademark Office. Coordinating patent and regulatory strategies for new drugs and biologics is also an important aspect of her work. Dr. Doherty is a frequent author and lecturer on patent law topics.
Close
Dr. Mandy J. Song, Ph.D.
Founding and Managing Partner
Bayes
Dr. Song, Ph.D. brings more than a decade’s experience in patent practice, including patent prosecution, client... | Read More
Dr. Song, Ph.D. brings more than a decade’s experience in patent practice, including patent prosecution, client counseling, patent portfolio management & transactions, patent litigation in U.S. federal district courts and Section 337 investigations at the U.S. International Trade Commission (ITC), and post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). She has significant experience in a wide range of electrical, computer, and biomedical technologies.
Close